CRISPR/Cas9 has been used to delete the MIEN1 gene in breast cancer models, delivered via cloning vectors such as [pSpCas9(BB)-2A-GFP (PX458)], which successfully silenced MIEN1 expression and inhibited disease progression (50). The gene discussed is MIEN1; the disease is breast cancer.